TherVacB Project Begins Patient Trial to Advance Curative Strategy for Chronic Hepatitis B
Chronic hepatitis B virus (HBV) infection remains a significant global health concern, affecting an estimated 254 million people worldwide and contri1
Chronic hepatitis B virus (HBV) infection remains a significant global health concern, affecting an estimated 254 million people worldwide and contri1
The Ministry of Science, Innovation and Universities announced this Friday the winners of the 2025 National Research Awards, one of the most prestigi1
An IDIBAPS team identifies a molecular interaction that drives the aggressiveness of lymphoma and proposes a new therapeutic strategy to combat it.
"La Caixa" Foundation will allocate €150,000 to the project led by Alba Rodríguez, from the IDIBAPS Cellular Immunotherapies for Cancer research grou1
A team led by Joan-Marc Servitja, from the IDIBAPS Pathogenesis and Prevention of Diabetes research group, has demonstrated in mouse models that high1
A systematic review published in eClinicalMedicine concludes that most antidepressants, when used appropriately, do not significantly increase the ri1
An international team led by the Clínic-IDIBAPS and the Institute of Cancer Research in London has developed an innovative new method based on DNA me1
Ferran Nadeu, a researcher in the IDIBAPS research group Molecular pathology of lymphoid neoplasms located at Esther Koplowitz Centre, has been awar1
A study led by the Clínic-IDIBAPS reveals that the microbiota can predict and enhance patient response to one of the most innovative immunotherapies1
Researchers from the Clinic-IDIBAPS lead an international study, published in The Lancet Respiratory Medicine, which demonstrates the importance of r1